Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Cemiplimab for Secondary Angiosarcomas

Phase 2

Completed

Conditions: Secondary Angiosarcoma
Locally Advanced Sarcoma
Metastasis

Interventions: Drug: Cemiplimab

First Posted Date: 2021-05-05

Last Posted Date: 2024-10-31

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 18

Registration Number: NCT04873375

Locations: 🇳🇱
RadboudUMC, Nijmegen, Netherlands

Safety and Efficacy of R0.6C Vaccine

Phase 1

Completed

Conditions: Malaria
Malaria,Falciparum

Interventions: Biological: R0.6C transmission blocking vaccine

First Posted Date: 2021-04-28

Last Posted Date: 2025-03-05

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 32

Registration Number: NCT04862416

Locations: 🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands

STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease

Not Applicable

Recruiting

Conditions: Movement Disorders
Parkinson Disease

Interventions: Behavioral: Step count increase with the use of a motivational smartphone application

First Posted Date: 2021-04-19

Last Posted Date: 2025-04-20

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 452

Registration Number: NCT04848077

Locations: 🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands

Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)

Phase 1

Completed

Conditions: SARS-CoV-2 Infection
Covid19
Severe Acute Respiratory Syndrome

Interventions: Biological: ABNCoV2 Vaccine

First Posted Date: 2021-04-09

Last Posted Date: 2024-02-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 45

Registration Number: NCT04839146

Locations: 🇳🇱
Radboud univserity medical center, Nijmegen, Gelderland, Netherlands

Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke

Phase 2

Recruiting

Conditions: Intracerebral Hemorrhage

Interventions: Drug: Anakinra

First Posted Date: 2021-04-08

Last Posted Date: 2024-11-18

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 75

Registration Number: NCT04834388

Locations: 🇳🇱
Radboudumc, Nijmegen, Netherlands

Real World Pharmacokinetics of Immune Checkpoint Inhibitors

Not Applicable

Terminated

Conditions: Cancer

Interventions: Other: blood sampling

First Posted Date: 2021-04-06

Last Posted Date: 2023-05-31

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 19

Registration Number: NCT04833075

Locations: 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands

Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study

Conditions: USH2A
Usher Syndrome, Type 2A
Retinitis Pigmentosa

Interventions: Other: No intervention

First Posted Date: 2021-03-29

Last Posted Date: 2022-04-29

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 36

Registration Number: NCT04820244

Locations: 🇳🇱
Radboud universitair medisch centrum, Nijmegen, Gelderland, Netherlands

Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms

Not Applicable

Completed

Conditions: Cognitive Symptoms
Cognitive Decline
Breast Cancer

Interventions: Other: Written information about potential chemotherapy-related cognitive symptoms without self-affirmation
Other: Written information about potential chemotherapy-related cognitive symptoms with self-affirmation

First Posted Date: 2021-03-24

Last Posted Date: 2021-03-24

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 148

Registration Number: NCT04813965

SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification

Not Applicable

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Diagnostic Test: SPIO-enhanced MRI

First Posted Date: 2021-03-17

Last Posted Date: 2022-10-26

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 10

Registration Number: NCT04803331

Locations: 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands

Testing New Vertical Dimension Of Occlusion Prior To Restorative Treatment Of Tooth Wear

Phase 2

Completed

Conditions: Vertical Dimension of Occlusion
Randomized Controlled Trial
Tooth Wear
Composite Resins

Interventions: Device: acrylic removable appliance

First Posted Date: 2021-03-15

Last Posted Date: 2021-03-15

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 49

Registration Number: NCT04797494

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy